Literature DB >> 3713512

Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons.

S Lillioja, J Foley, C Bogardus, D Mott, B V Howard.   

Abstract

We have examined the relationship of free fatty acid (FFA) turnover and lipid oxidation rates in vivo to the size of body triglyceride stores and compared these findings with the in vitro lipolytic rates of isolated abdominal fat cells. The studies were performed in 20 Pima Indian women 18 to 35 years of age, both lean and obese. FFA turnover rate was measured using a 1-14C-palmitate infusion, lipid oxidation rate by indirect calorimetry using a ventilated hood, body composition by underwater weighing with correction for residual lung volume, and fat cell lipolytic rates in vitro by published methods. Both FFA turnover and lipid oxidation rates, expressed per kg of body fat, decreased with increasing degree of obesity (as measured by percent body fat) (r = -0.90, and r = -0.75, P less than or equal to 0.0001, respectively). In contrast, the rate of lipolysis determined in vitro, expressed per kg of fat, increased with increasing degree of obesity (r = 0.58, P less than 0.01). A ratio of FFA turnover/lipolysis, which directly compares these in vivo and in vitro measurements, decreased significantly with increases in the degree of obesity (r = -0.81, P less than or equal to 0.0001). Furthermore, there were no positive correlations between the measures of in vivo FFA metabolism and in vitro lipolysis when both were expressed per fat mass, per fat cell number, or per fat cell surface area. The in vivo data also demonstrated that lipid oxidation could only account for 50% of the FFA disappearance rate. While lipid oxidation rate adjusted to the metabolic size increased with increasing plasma FFA concentration (r = 0.75, P less than 0.0003), the nonoxidative component of the FFA turnover failed to increase with increases in plasma FFA concentration (P = 0.5). We conclude that FFA is not available in vivo in proportion to the size of the triglyceride stores. The reason for this is not due to an inability of fat cells to release their stored triglyceride as assessed in vitro. Hence, in vitro measurements of fat cell lipolysis cannot be used to directly predict in vivo FFA metabolism. The large nonoxidative FFA disposal is likely to be important in the regulation of plasma FFA concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713512     DOI: 10.1016/0026-0495(86)90006-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM.

Authors:  G Paolisso; P A Tataranni; J E Foley; C Bogardus; B V Howard; E Ravussin
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

2.  Effects of high-fat diet and AMP-activated protein kinase modulation on the regulation of whole-body lipid metabolism.

Authors:  Milena Schönke; Julie Massart; Juleen R Zierath
Journal:  J Lipid Res       Date:  2018-05-08       Impact factor: 5.922

3.  Gender differences in insulin-induced free fatty acid suppression: studies in an African American population.

Authors:  A E Sumner; H Kushner; C A Lakota; B Falkner; J B Marsh
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Expression profile in omental and subcutaneous adipose tissue from lean and obese subjects. Repression of lipolytic and lipogenic genes.

Authors:  Carmen Hurtado del Pozo; Rosa María Calvo; Gregorio Vesperinas-García; Javier Gómez-Ambrosi; Gema Frühbeck; Miguel Angel Rubio; Maria Jesus Obregon
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

Review 5.  Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment.

Authors:  T Vogt; D Belluscio
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

6.  Glycerol production in subcutaneous adipose tissue in lean and obese humans.

Authors:  P A Jansson; A Larsson; U Smith; P Lönnroth
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Skeletal muscle membrane lipid composition is related to adiposity and insulin action.

Authors:  D A Pan; S Lillioja; M R Milner; A D Kriketos; L A Baur; C Bogardus; L H Storlien
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  Role of lipids in development of noninsulin-dependent diabetes mellitus: lessons learned from Pima Indians.

Authors:  P A Tataranni; L J Baier; G Paolisso; B V Howard; E Ravussin
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

9.  Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity.

Authors:  J M Kaartinen; S P Hreniuk; L F Martin; S Ranta; K F LaNoue; J J Ohisalo
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

10.  Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia.

Authors:  L D Monti; P Brambilla; I Stefani; A Caumo; F Magni; R Poma; L Tomasini; G Agostini; M Galli-Kienle; C Cobelli
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.